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Abstract The human endogenous retrovirus K (HERV-K)-
encoded protein cORF has recently been shown to be a functional
homolog of the HIV Rev protein. Rev-mediated RNA export
requires interaction between a leucine-rich nuclear export signal
(NES) in Rev and the nuclear export receptor Crm1/exportin1.
Like Rev, cORF binds to Crm1 and cORF-mediated RNA
export depends on Crm1 activity. Here we document that
mutation of the putative NES in cORF results in trapping of the
protein in the nucleus, suggesting that the cORF NES functions
in analogy to the Rev NES.
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1. Introduction
The human genome consists to about 1% of retroviral se-
quences. Most of these human endogenous retroviruses
(HERVs) are defective and only the family HERV-K is
known to possess intact open reading frames (ORFs) for all
essential retroviral proteins [1^3]. Recently, almost complete
representatives of this family were identi¢ed [4,5]. HERV-K is
expressed in a complex splicing pattern in testicular tumors
and derived cell lines as well as in normal testis and placenta
[1,6]. HERV-K expression is tightly associated with testicular
malignancies [7].
The family HERV-K encodes an accessory protein, cORF
(central ORF), translated from a doubly spliced RNA [8], in
addition to the basic proteins with structural or enzymatic
functions encoded by the genes gag, prt, pol and env. In com-
plex exogenous retroviruses, accessory proteins often have
regulatory functions and are important for e⁄cient virus in-
fectivity. For example, the proteins Tat and Rev of human
immunode¢ciency virus (HIV) regulate gene expression on the
transcriptional or the post-transcriptional level [9]. Rev medi-
ates the nuclear export of incompletely spliced HIV RNA. In
the absence of Rev, the intron-containing HIV RNA species
that code for the structural proteins are retained to the nu-
cleus unless completely spliced. Rev enters the nucleus via its
N-terminal nuclear localization signal (NLS) and uses its
NLS-containing protein domain to bind to an RNA second-
ary structure (Rev-responsive element, RRE) within intron-
containing HIV mRNAs. The C-terminal nuclear export sig-
nal (NES) of Rev then binds to the cellular export receptor
Crm1 (or exportin1, reviewed in [10]), most likely in concert
with other Rev- or Crm1-binding co-factors like eukaryotic
initiation factor 5A (eIF-5A), the nucleoporin hRIP/Rab or
the nucleoporin-like protein 1 (NLP-1) [11^14]. As a conse-
quence, Rev is transported back to the cytoplasm (‘nucleo-
cytoplasmic shuttling’) with the bound RNA backpacked [15].
The cORF protein resembles the Rev protein with respect
to structural features and intracellular localization [8]. cORF
possesses putative NLS and NES sequences and has been
clearly demonstrated to exert a Rev-homologous function.
In analogy to Rev, cORF supports the export of mRNA
containing a de¢ned sequence of the HERV-K mRNA. Ac-
cording to the RRE, this sequence was named RcRE. Addi-
tionally it was shown that a speci¢c inhibitor of Crm1-medi-
ated export, leptomycin B (LMB), is able to block the cORF-
mediated accumulation of RcRE-containing RNA transcripts
in the cytoplasm [16]. Furthermore, cORF directly binds to
Crm1 [17]. This provides strong evidence that cORF, like Rev,
uses the Crm1 export pathway to shuttle between the nucleus
and the cytoplasm. However, the involvement of the putative
Rev-like NES in this process has not been characterized. We
show here that the putative NES in cORF permits a partly
cytoplasmic location of the protein while mutation of this
sequence or Crm1 inhibition result in nuclear inclusion of
cORF.
2. Materials and methods
2.1. Plasmid constructions
The plasmid pEGFP-wtcORF was constructed by inserting full-
length cORF in-frame into the BamH1-digested pEGFP-C1 vector
(Clontech). pEGFP-cORFMuNES was constructed as follows: An
N-terminal and a C-terminal fragment of the cORF gene were ampli-
¢ed by PCR using the primers (1) 5P-AGCAGAGCTCGTTTAGT-
GAA-3P (mapping upstream of the multiple cloning site in the pCEP4-
cORF vector containing full-length cORF) and (2) 5P-AGCTGCCT-
GCGTCGCCTTCTTTGCTTGTGC-3P (mutating the putative NES),
and the primers (3) 5P-GCACAAGCAAAGAAGGCGACGCAGGC-
AGCT-3P (complementary to (2)) and (4) 5P-CACTGCATTCTAGT-
TGTGG-3P (mapping in pCEP4-cORF downstream of the binding
site). Puri¢ed fragments were mixed and subjected to a PCR generat-
ing full-length fragments (by annealing of the overlapping part) that
were subsequently ampli¢ed using primers (1) and (4), digested and
inserted into the BamH1 site of pEGFP-C1.
2.2. Cell culture, transfection and leptomycin B treatment
Tera-1 cells (teratocarcinoma cells expressing HERV-K) were
grown in McCoy’s 5A medium (GIBCO BRL) supplemented with
10% FCS and were subcultured routinely once per week. Cells were
seeded and grown to about 50% con£uency on glass cover slips and
were then transfected using the E¡ectene transfection reagent (Qia-
gen). 48 h after transfection, cells were ¢xed in paraformaldehyde (4%
in PBS), stained with 200 ng/ml 4P,6-diamidino-2-phenylindole
(DAPI) in methanol to visualize nuclei, and intracellular localization
of EGFP fusion proteins was then studied by £uorescence microsco-
py. Where required, 50 nM leptomycin B was added to the culture
medium 48 h after transfection and 16 h prior to evaluation.
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3. Results and discussion
3.1. HERV-K cORF protein is located in the nucleus and in the
cytoplasm
Previous studies have shown that immunohistochemistry
detects cORF protein most prominently in the nucleoli of
the HERV-K expressing teratocarcinoma cell lines Tera-2
and GH [8]. It was proposed that an arginine-rich stretch of
amino acids in the N-terminus of cORF (aa 13^20) may serve
as the nuclear (and nucleolar) localization signal, while a cen-
tral region (aa 50^59) with similarities to the consensus se-
quence of Rev-type NESs (reviewed in [18]) may act as a
nuclear export signal [8]. A comparison of the proposed
cORF NES [8] and the consensus Rev-like NES is given in
Fig. 1. Hence, the subcellular localization of cORF might
re£ect the steady-state picture of a protein that shuttles be-
tween the cytoplasm and the nucleus, as is the case with Rev.
The nucleolar accumulation and the apparent absence of
cORF from the cytoplasm in some immunostainings may mir-
ror the di⁄culties in detecting low protein concentrations with
£uorescence labelled antibodies.
Not only teratocarcinoma cell lines, but also Raji cells sta-
bly transfected to express cORF display a primarily nucleolar
localization of cORF in immunohistochemical stainings using
a cORF-speci¢c antiserum. However, Western blot analysis of
cellular subfractions revealed that cORF is not only present in
the nuclear but also in the cytosolic fraction (data not shown).
To investigate intracellular distribution of the cORF protein
in a system achieving strong £uorescence we decided for an
enhanced green £uorescent protein (EGFP)-based approach.
Cells were transfected with the plasmid pEGFP-wtcORF en-
coding wild-type (wt) cORF protein fused to an EGFP do-
main (EGFP-wtcORF). Fig. 2A shows the distribution of
EGFP-wtcORF protein in the nucleus (made visible with
DAPI in Fig. 2B) and in the cytoplasm of transfected Tera-
1 cells. This distribution pattern is observed in 92% of the
evaluated cells. In all assays presented, only cells were eval-
uated that showed an intact nuclear morphology and did not
show signs of ongoing cell division or apoptosis. For any of
the stated percent values at least 1500 cells that meet the
evaluation criteria were inspected.
3.2. E⁄cient nuclear export of cORF protein depends on a
leucine-rich domain
To examine whether the cytoplasmic localization of EGFP-
wtcORF is a result of nuclear export via the Crm1 pathway,
Crm1-dependent nuclear export was blocked by addition of
50 nM LMB. In the presence of LMB, EGFP-wtcORF shows
an exclusively nuclear staining in 76% of the evaluated cells
(Fig. 2C and D). The absence of wtcORF from the cytoplasm
following disruption of the nuclear export machinery supports
the notion that the cytoplasmic location of cORF results from
active re-export of cORF from the nucleus rather than from
cytoplasmic retention of the protein.
Subsequently, the putative NES sequence in cORF was
mutated (cORFmuNES) by changing leucine residues that
are known to be critical for the export mediated by Rev-like
NESs, to alanine residues (Fig. 1). Though the putative cORF
NES does not exactly match the proposed consensus se-
quence, cORFmuNES expressed as an EGFP fusion
(EGFP-cORFmuNES) was found to be exclusively localized
in the nucleus (Fig. 2E and F) in 83% of the evaluated cells.
In this report we demonstrated that the presence of
wtcORF protein in the cytoplasm depends on an active nu-
clear export mechanism and on a leucine-rich signal in the
central part of cORF. Leucine-rich NESs of the Rev-type
bind to the nuclear export receptor Crm1 and the NES-con-
taining proteins are subsequently transported to the cyto-
plasm. cORF, the proposed HERV-K counterpart of Rev,
was described to also bind to Crm1. If Crm1 is functionally
inhibited, cORF localization is restricted to the nucleus (Fig.
2C, D and [17]) and cORF lacks its RNA export function
[16,17]. We show that a NES mutant of cORF (Fig. 2E, F)
mimics the intracellular localization seen after blocking of the
Crm1 pathway. Therefore, our data provide additional evi-
Fig. 1. Domains in cORF representing putative nuclear im- and ex-
port signals as proposed in [8]. The putative cORF NES is shown
in the wt and in the mutated form with the leucine to alanine ex-
changes given in bold. The consensus Rev-like NES (leucine residues
essential for nuclear export indicated in bold) is shown in compari-
son.
Fig. 2. Intracellular distribution of cORF protein. Tera-1 cells were
transfected with EGFP-wtcORF (A, B, C, D) or EGFP-cORF-
muNES (E, F) encoding plasmids and were (C, D) or were not (A,
B, E, F) treated with LMB. EGFP £uorescence is seen in (A), (C)
and (E), DAPI stains of the same cells indicate the nuclei (marked
by arrowheads in B, D and F). All observed localization phenotypes
are reproducible in various human and murine cell lines.
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dence to enforce the model that cORF is not only a functional
Rev homolog but shuttles via the same biochemical pathway,
involving interaction of a leucine-rich NES and Crm1.
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